Results 211 to 220 of about 4,014,458 (336)

Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activity

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Prednisone is a widely used glucocorticoid in the treatment of lupus, although its dosing is often determined empirically. Prednisolone, the active metabolite of prednisone, is found in its free form in the serum. The goal of this study was to develop a population pharmacokinetic model in patients with systemic lupus erythematosus (SLE ...
Naïm Bouazza   +26 more
wiley   +1 more source

Inpatient Psychiatric Unit Availability Within US Short-Term, Acute-Care Hospitals, 2011-2023.

open access: yesJAMA Netw Open
Lindenfeld Z   +4 more
europepmc   +1 more source

Civil Monetary Penalties from Violations of the Emergency Medical Treatment and Labor Act for Patients Arriving or Leaving with Law Enforcement. [PDF]

open access: yesWest J Emerg Med
Ahmed S   +11 more
europepmc   +1 more source

Expert insight into the education of healthcare professionals on medication adherence

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Medication non‐adherence is a global health problem affecting patients with numerous medical conditions. Training healthcare professionals (HCPs) on managing the challenging issue of medication non‐adherence requires an evidence‐based approach.
Fatima Rezae   +3 more
wiley   +1 more source

Mortality in national psychiatric hospitals in Sudan: a fifteen-year review of hospital deaths. [PDF]

open access: yesBMC Psychiatry
Hussein M Osman A   +4 more
europepmc   +1 more source

The use of international classification of diseases codes to identify hospital admissions linked with adverse drug events: Validation study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Several methods exist to identify hospital admissions related to adverse drug events (ADEs). Clinical adjudication by healthcare professionals is the gold standard but is labour‐intensive. Spontaneous reporting and routinely collected healthcare data using a set of International Classification of Diseases (ICD) codes often underestimate the ...
Zuzana Juhásová   +2 more
wiley   +1 more source

Contribution of Addictovigilance data to assess adverse‐events linked to psychoactive substances in children and adolescents

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims We sought to characterize adverse events and deaths associated with the use of psychoactive substances in children and adolescents. Methods Two French Addictovigilance databases were analysed: spontaneous reports and deaths over the period 2016–2021, in subjects aged 10–<18 years. An unsupervised classification was implemented on consumption data (
Hélène Peyrière   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy